Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity

v3.24.3
Stockholders' Equity
 9 Months Ended
Sep. 30, 2024
Stockholders' Equity Note [Abstract]  
Stockholders' Equity

11. Stockholders’ Equity

As of September 30, 2024, there were 1,000,000,000 shares of common stock authorized, 328,412,061 shares of common stock issued, and 322,239,140 shares of common stock outstanding.

As of December 31, 2023, there were 1,000,000,000 shares of common stock authorized, 318,366,628 shares of common stock issued, and 315,192,401 shares of common stock outstanding.

As of September 30, 2024 and December 31, 2023, there were 5,000,000 shares of preferred stock authorized and none were issued or outstanding.

During the nine months ended September 30, 2024, we withheld a total of 2,998,694 shares in order to satisfy payroll tax withholdings to settle cashless stock option exercises.

We use the cost method to account for treasury stock. As of September 30, 2024 and December 31, 2023, we had 6,172,921 and 3,174,227 shares, respectively, of treasury stock. As of September 30, 2024 and December 31, 2023, the cost of treasury stock included in additional paid-in capital in the accompanying consolidated balance sheets was $28,895 and $6,091, respectively.